$1 million fine for biosafety snafus

Texas A&M University will pay an unprecedented $1 million in fines for more than a dozen safety violations in its research program on bioterrorism agents, the university announced today (February 20). The Centers for Disease Control and Prevention linkurl:suspended;http://www.the-scientist.com/blog/display/54082/ the university's bioterrorism research efforts in July, 2007, after an inspection prompted by the biosafety watchdog group, the linkurl:Sunshine Project,;http://www.the-scientist.com/b

Written byAlla Katsnelson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Texas A&M University will pay an unprecedented $1 million in fines for more than a dozen safety violations in its research program on bioterrorism agents, the university announced today (February 20). The Centers for Disease Control and Prevention linkurl:suspended;http://www.the-scientist.com/blog/display/54082/ the university's bioterrorism research efforts in July, 2007, after an inspection prompted by the biosafety watchdog group, the linkurl:Sunshine Project,;http://www.the-scientist.com/blog/display/54293/ uncovered the linkurl:safety lapses.;http://www.the-scientist.com/news/display/53626/ The university proposed the sum to the Office of Inspector General, which levies such fines according to Health and Human Services Department regulations, and learned this afternoon that the OIG has agreed, Elsa Murano, president of Texas A&M, said in a press teleconference. Does that mean that the university acknowledges the safety breaches, which included three workers' exposure to the bacteria Brucella and another pathogen which causes Q fever? "Essentially, yes," she said. Murano said the university "proactively" proposed the large fine "so that others will realize that this is the type of financial agreement they should expect to make when standards are not maintained." Texas A&M intends "to develop a model program for research and compliance in this area," she said. Rules for handling the class of especially dangerous pathogens termed "select agents" have been in place since 2002. Until now, most violations have resulted in linkurl:fines;http://oig.hhs.gov/fraud/enforcement/administrative/cmp/cmpitems.html#6 ranging from approximately $12,000 to $50,000. In one exception, the University of California was fined $450,000 after it incorrectly shipped anthrax. Last September, Texas A&M proposed a fine of $10,000. Murano declined to say how officals settled on the $1 million figure, noting that she began her position as president of the university just six weeks ago. Early next month, the CDC will send a team to re-inspect labs working on bioterrorism agents to determine whether the university can resume select agent work, Murano said. The university has an $18 million grant from the Department of Homeland Security for research on bioterrorism agents.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies